Back
EPAM Systems 10K Form
Sell
6
EPAM
EPAM Systems
Last Price:
189.33
Seasonality Move:
10.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | EPAM/EPAM Systems Quarterly |
2023-11-03 | 10Q | EPAM/EPAM Systems Quarterly |
2023-08-03 | 10Q | EPAM/EPAM Systems Quarterly |
2023-05-05 | 10Q | EPAM/EPAM Systems Quarterly |
2022-11-04 | 10Q | EPAM/EPAM Systems Quarterly |
2022-08-05 | 10Q | EPAM/EPAM Systems Quarterly |
Receive EPAM News And Ratings
See the #1 stock for the next 7 days that we like better than EPAM
EPAM Financial Statistics
Sales & Book Value
Annual Sales: | $4.69B |
---|---|
Cash Flow: | $52.32M |
Price / Cash Flow: | 20.28 |
Annual Sales: | $59.67 |
Price / Book: | 3.17 |
Profitability
EPS (TTM): | 6.98000 |
---|---|
Net Income (TTM): | $409.65M |
Gross Margin: | $1.43B |
Return on Equity: | 12.11% |
Return on Assets: | 9.66% |
EPAM Systems Earnings Forecast
Key EPAM Systems Financial Ratios
- The Gross Profit Margin over the past 15 years for EPAM is 30.57%.
- The Selling, General & Administrative Expenses for EPAM have been equal to 17.38% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.36% of Operating Income.
- The Net Earning history of EPAM is 8.89% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 10 years.
EPAM Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | IT Services |
Sector: | Information Technology |
Current Symbol: | EPAM |
CUSIP: | 29414B |
Website: | epam.com |
Debt
Debt-to-Equity Ratio: | 0.01 |
---|---|
Current Ratio: | 4.84 |
Quick Ratio: | 4.66 |
Price-to-Earnings
Trailing P/E Ratio: | 26.81 |
---|---|
Forward P/E Ratio: | 17.22 |
EPAM Technical Analysis vs Fundamental Analysis
Sell
6
EPAM Systems (EPAM)
is a Sell
Is EPAM Systems a Buy or a Sell?
-
EPAM Systems stock is rated a Sell
The current EPAM Systems [EPAM] share price is $189.30. The Score for EPAM is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.